SEC counts one filing for TRP selling 90 million IPO shares to raise funds to build a hospital. The first facial surgery in Thailand

Mr. Ekachak Buahapakdee, Managing Director of Capital One Partners Public Company Limited, acting as financial advisor to Aesthetic Connect Public Company Limited (TRP), revealed that the Securities and Exchange Commission (SEC) has commenced the review process for TRP's application for permission to offer securities and its registration statement for the initial public offering (IPO). TRP is seeking to offer 90 million newly issued ordinary shares to the public for the first time, with a par value of 0.50 baht per share, representing 25.71% of the total shares after the IPO. The company plans to list on the Market for Alternative Investment (mai) within this year.
TRP is a medical clinic operating under the name "Theeraporn Clinic," providing facial cosmetic surgery services to the general public. It was founded by Assistant Professor Dr. Choltis Sinrachatanan, former president of the Thai Society of Facial Plastic Surgery, a specialist with over 40 years of experience in facial plastic surgery. He is supported by a team of highly experienced specialist doctors, widely recognized in the field of surgery, and equipped with comprehensive, modern, and internationally standardized medical equipment. The clinic offers services in three main areas :
- Providing surgical procedures Including facelift surgery with the Face-Lock innovation to solve various problems on the face, double eyelid surgery with the Eye-Lock technique, a unique technique invented by Assistant Professor. Dr. Chonlatit and the Teeraporn medical team including nose surgery and surgery on other parts of the face
- Intravenous anesthesia service By an anesthesiologist with expertise
- Non-surgical services Such as Botox injections, Filler injections, using frequency equipment to tighten the skin, giving vitamins for a clear face. and provide other skin services such as LED light curing, mesofat injections and thread lifting, etc.
Assistant Professor Dr. Choltis Sinrachatanan, CEO of TRP, stated that the company plans to use the proceeds to invest in business expansion projects such as research development in various fields, construction of a facial plastic surgery hospital, and as working capital to enhance the company's service capabilities in the future.
In terms of operating results for the past 3 years (2563-2565), the company had total income of 221.60 million baht, 427.76 million baht, and 854.07 million baht, respectively, and net profits of 37.15 million baht, 112.68 million baht, and 270.27 million baht, respectively.
For the first 6 months of 2566, there was a total income of 369.05 million baht and a net profit of 105.48 million baht.
The CEO of TRP stated that the company is ready to become the first comprehensive facial cosmetic surgery hospital in Thailand, in order to increase business opportunities in providing facial cosmetic surgery services, which are growing in line with the increasing number of Thai and international patients, and to align with the increasingly open trends in beauty.






























